Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Aflibercept in Resected Metastatic Colorectal Cancer
NCT01669720Phase 2Terminated
- Sponsor
- Brown University
- Start
- Dec 2012
- Primary completion
- Dec 2015
- Modality
- Engineered Antibody Formats, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of aflibercept in colorectal cancer (metastatic) (mCRC), sponsored by Brown University. Started Dec 2012; status: terminated.
02
Drugs
aflibercept
03
Conditions
colorectal cancer (metastatic) (mCRC)
Beyond the preview
Go deeper on NCT01669720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01669720.